Lv2
130 积分 2024-01-30 加入
Direct-Acting Antiviral Agents in Hepatitis C–Associated Indolent Lymphomas
1个月前
已完结
4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial
1个月前
已完结
The Treatment of Marginal Zone Lymphoma
1个月前
已完结
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
2个月前
已完结
Engaging results with glofitamab in DLBCL
2个月前
已关闭
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
2个月前
已完结
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab
2个月前
已完结
Lenalidomide attenuates cardiac fibrosis and inflammation induced by β-adrenergic receptor activation
2个月前
已完结
The best matrix for the brain: advances in secondary CNS lymphoma
3个月前
已关闭
β-Sitosterol Inhibits Tumor Growth and Amplifies Rituximab Sensitivity through Acid Sphingomyelinase/Ceramide Signaling in Diffuse Large B-Cell Lymphoma
4个月前
已完结
皖公网安备34019202002308
